 The future of nanomedicine: Promises and limitationsR. L. Juliano Science and Public Policy, 2012, vol. 39, issue 1, 99-104 Abstract: The nascent field of nanomedicine has evoked enormous interest among physical and biological scientists and has already attracted hundreds of millions of dollars of research funding. The great appeal of nanomedicine lies in its promise of using the unique properties of nanoscale materials to address some of the most challenging problems of medical diagnosis and therapy. While some questions have been raised about the possible toxicities of nanomaterials, and about the ethical implications of applying these advanced, but undoubtedly expensive, technologies to medical practice, for the most part nanomedicine has enjoyed unalloyed enthusiasm from both its proponents in the research community and from policy makers. However, will the promise of nanomedicine actually be fulfilled? This paper discusses the internal intellectual culture of nanomedicine and how that gives rise to problems and contradictions that may slow its evolution and introduction into clinical practice. Copyright The Author 2012. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com, Oxford University Press. Date: 2012 Downloads: (external link) Related works: Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text Persistent link: https://EconPapers.repec.org/RePEc:oup:scippl:v:39:y:2012:i:1:p:99-104 Access Statistics for this article Science and Public Policy is currently edited by Nicoletta Corrocher, Jeong-Dong Lee, Mireille Matt and Nicholas Vonortas More articles in Science and Public Policy from Oxford University Press |
Is your work missing from RePEc? Here is how to contribute.
Questions or problems? Check the EconPapers FAQ or send mail to .
EconPapers is hosted by the
School of Business at Örebro University.